XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Segment Information (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Segment Reporting [Abstract] |
Schedule of Segment Information | The following segment information has been prepared in accordance with the internal accounting policies of Abbott, as described above, and is not presented in accordance with generally accepted accounting principles applied to the condensed consolidated financial statements.
|  | Net Sales to External Customers |  | Operating Earnings
|  | Three Months Ended March 31 |  | Three Months Ended March 31
(in millions) |  | 2024 |  | 2023 |  | 2024 |  | 2023
Established Pharmaceutical Products |  | $ | 1,226 |  |  | $ | 1,189 |  |  | $ | 267 |  |  | $ | 300 |
Nutritional Products |  | 2,068 |  |  | 1,967 |  |  | 377 |  |  | 380 |
Diagnostic Products |  | 2,214 |  |  | 2,688 |  |  | 474 |  |  | 651 |
Medical Devices |  | 4,453 |  |  | 3,900 |  |  | 1,360 |  |  | 1,078 |
Total Reportable Segments |  | 9,961 |  |  | 9,744 |  |  | 2,478 |  |  | 2,409 |
Other |  | 3 |  |  | 3 |  |  |  |  |
Net sales |  | $ | 9,964 |  |  | $ | 9,747 |  |  |  |  |
Corporate functions and benefit plan costs |  |  |  |  |  | (66) |  |  | (77) |
Net interest expense |  |  |  |  |  | (61) |  |  | (52) |
Share-based compensation (a) |  |  |  |  |  | (304) |  |  | (281) |
Amortization of intangible assets |  |  |  |  |  | (472) |  |  | (491) |
Other, net (b) |  |  |  |  |  | (139) |  |  | 54 |
Earnings before taxes |  |  |  |  |  | $ | 1,436 |  |  | $ | 1,562 |
______________________________________
(a) | Approximately 45 percent of the annual net cost of share-based awards will typically be recognized in the first quarter due to the timing of the granting of share-based awards.
(b) | Other, net for the three months ended March 31, 2024 and March 31, 2023 includes charges related to restructuring actions. Other, net for the three months ended March 31, 2024 also includes integration costs associated with the acquisition of CSI and $38 million related to various investment impairments.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration